Impella 5.5®
Overview
The Impella 5.5 with SmartAssist heart pump delivers full cardiac support, allowing the heart to rest and enabling the heart to achieve its natural pumping function without additional support. In the United States, this heart pump is indicated for up to 14 days use, enables patient mobility and optimizes recovery by using real-time intelligence.
For Patients Experiencing
Keith Brown needed escalated care. He received Impella 5.5 with SmartAssist, and his heart recovered in four days
Are you a health care professional?
Visit heartrecovery.com to access instructions for use and other clinical materials.
Indications for Use
The Impella 5.5® with SmartAssist® System is a temporary ventricular support device intended for short term (14 days) use and indicated for the treatment of ongoing cardiogenic shock that occurs immediately (< 48 hours) following acute myocardial infarction or open heart surgery or in the setting of cardiomyopathy, including peripartum cardiomyopathy, or myocarditis as a result of isolated left ventricular failure that is not responsive to optimal medical management and conventional treatment measures (including volume loading and use of pressors and inotropes, with or without IABP). The intent of Impella System Therapy is to reduce ventricular work and to provide the circulatory support necessary to allow heart recovery and early assessment of residual myocardial function.
Acute renal dysfunction, Aortic valve injury, Bleeding, Cardiogenic shock, Cerebral vascular accident/Stroke, Death, Hemolysis, Limb ischemia, Myocardial infarction, Renal failure, Thrombocytopenia and Cardiac or Vascular injury (including ventricular perforation). In addition to the risks above, there are other WARNINGS and PRECAUTIONS associated with Impella devices. To learn more, visit: https://www.abiomed.com/important-safety-information.
Acute renal dysfunction, Aortic valve injury, Bleeding, Cardiogenic shock, Cerebral vascular accident/Stroke, Death, Hemolysis, Limb ischemia, Myocardial infarction, Renal failure, Thrombocytopenia and Cardiac or Vascular injury (including ventricular perforation). In addition to the risks above, there are other WARNINGS and PRECAUTIONS associated with Impella devices. To learn more, visit: https://www.abiomed.com/important-safety-information.
IMP-1697